Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sheila L. Stadler"'
Autor:
Cari R. Friesleben, Stephanie M. Campbell, Jessica M. Stine, Jennifer J. Schimmer, Kari L. Olson, Jessica Angleson, Sheila L. Stadler
Publikováno v:
Journal of the American Pharmacists Association. 62:604-611
OBJECTIVE This study aimed to compare lipid and blood pressure (BP) control before and after implementing a certified pharmacy technician (CPhT) protocol that optimized electronic health record (EHR) capabilities and shifted work from clinical pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07aa5dcea11b09e8f637b71fd6e59364
https://doi.org/10.1016/j.japh.2021.10.014
https://doi.org/10.1016/j.japh.2021.10.014
Publikováno v:
Annals of Pharmacotherapy. 51:140-145
Background: Against-label prescribing of statins with interacting drugs, such as cyclosporine, represents an important patient safety concern. Objective: To implement and evaluate the effectiveness of a clinical pharmacist patient-safety initiative t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eb6e5a5e654f96c0f7d3c5df525c18b
https://doi.org/10.1177/1060028016675352
https://doi.org/10.1177/1060028016675352
Autor:
Sheila L, Stadler, Thomas J, Cook
Publikováno v:
The American journal of managed care. 23
In patients with hypercholesterolemia who have atherosclerotic cardiovascular disease and/or familial hypercholesterolemia, a new class of drugs may be helpful in reducing serum levels of low-density lipoprotein cholesterol (LDL-C) beyond maximally t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3418871453d51e1868e8f733ff60a03
https://pubmed.ncbi.nlm.nih.gov/28978220
https://pubmed.ncbi.nlm.nih.gov/28978220
Autor:
Michele Wood, Kari L. Olson, Anne M. Denham, Sheila L. Stadler, Roseanne Hornak, Leslie K. Ruppe, Thomas Delate
Publikováno v:
Pharmacy Practice
Pharmacy Practice (Granada), Volume: 17, Issue: 2, Article number: 1402, Published: 18 NOV 2019
Pharmacy Practice, Vol 17, Iss 2, p 1402 (2019)
Pharmacy Practice (Granada) v.17 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice (Granada), Volume: 17, Issue: 2, Article number: 1402, Published: 18 NOV 2019
Pharmacy Practice, Vol 17, Iss 2, p 1402 (2019)
Pharmacy Practice (Granada) v.17 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background: High intensity statin therapy (HIST) is the gold standard therapy for decreasing the risk of recurrent atherosclerotic cardiovascular disease (ASCVD); however, little is known about the use of HIST in older adults with ASCVD. Objectives:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8091a20598af7663adb8ddd5b5aeda
https://doi.org/10.18549/pharmpract.2019.2.1402
https://doi.org/10.18549/pharmpract.2019.2.1402
Autor:
Kari L. Olson, Leslie K. Ruppe, Elizabeth C. Cannon, Sarah D. Sutton, Deanna Kurz, Sheila L. Stadler, Emily Zadvorny
Publikováno v:
American Journal of Pharmaceutical Education. 83:6759
Objective. To assess the value of an advanced pharmacy practice experience in which students engaged in population health management (PHM) activities for a managed care setting. Methods. Students were provided with a list of patients, trained on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f5dc72848ea91ad586969cdcce19af
https://doi.org/10.5688/ajpe6759
https://doi.org/10.5688/ajpe6759
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 73(18)
Purpose Prescribing practices within a clinical pharmacy cardiac risk service (CPCRS) and their impact on treatment outcomes in patients with atherosclerotic cardiovascular disease (ASCVD) are described. Summary National healthcare reforms have incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a043c4cb823e05346a895517a858dba
https://pubmed.ncbi.nlm.nih.gov/27605323
https://pubmed.ncbi.nlm.nih.gov/27605323
Publikováno v:
Journal of Clinical Lipidology. 4:298-304
Patients with chronic kidney disease (CKD) are at significant risk for cardiovascular disease (CVD). The National Kidney Foundation developed clinical practice guidelines (Kidney Disease Outcomes Quality Initiative) for targeting low-density lipoprot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd73da802f1cfe37b04bc1c35ccf7ff
https://doi.org/10.1016/j.jacl.2010.06.005
https://doi.org/10.1016/j.jacl.2010.06.005
Publikováno v:
Journal of Clinical Lipidology. 9:436-437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4df176a9c58be59c07afb22685f06d67
https://doi.org/10.1016/j.jacl.2015.03.046
https://doi.org/10.1016/j.jacl.2015.03.046
Autor:
Todd, Brittany A.1,2 brittany.x.todd@kp.org, Lamprecht Jr., Donald G.1,2, Stadler, Sheila L.2,3
Publikováno v:
American Journal of Health-System Pharmacy. 9/15/2016, Vol. 73 Issue 18, p1442-1450. 9p. 3 Diagrams, 1 Chart.
Autor:
Lamprecht Jr, Donald G., Todd, Brittany A., Denham, Anne M., Ruppe, Leslie K., Stadler, Sheila L., Lamprecht, Donald G Jr
Publikováno v:
Annals of Pharmacotherapy; Feb2017, Vol. 51 Issue 2, p140-145, 6p